GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease
Open Access
- 1 June 2016
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 376 (1) , 104-109
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Whole-genome analysis informs breast cancer response to aromatase inhibitionNature, 2012
- Higher levels of GATA3 predict better survival in women with breast cancerHuman Pathology, 2010
- GATA-3 Links Tumor Differentiation and Dissemination in a Luminal Breast Cancer ModelCancer Cell, 2008
- Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathwayMolecular Cancer, 2008
- Origins of breast cancer subtypes and therapeutic implicationsNature Clinical Practice Oncology, 2007
- GATA-3 Maintains the Differentiation of the Luminal Cell Fate in the Mammary GlandCell, 2006
- Associations between gene expressions in breast cancer and patient survivalHuman Genetics, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- GATA3 haplo-insufficiency causes human HDR syndromeNature, 2000